Back to results
US 10,952,962 B1Granted
Ready to use liquid formulation
AssigneeQuVa Pharma, Inc.
InventorsTravis A. Leeah, Jianping Chen
Life of this patent
Estimating the term…
Abstract
Disclosed herein is a ready-to-use liquid formulation comprising lidocaine hydrochloride and epinephrine hydrochloride. Also disclosed herein is a process for preparing a ready-to-use liquid formulation comprising lidocaine hydrochloride and epinephrine hydrochloride, as well as methods for using the ready-to-use liquid formulation.
Claims16
A ready-to-use liquid formulation comprising:
- lidocaine hydrochloride in an amount of about 10 mg/mL or about 20 mg/mL;
- epinephrine hydrochloride in an amount of about 10 mcg/mL, based on epinephrine free base;
- sodium chloride in an amount of about 7 mg/mL;
- sodium metabisulfite in an amount of about 5.2 mcg/mL;
- citric acid in an amount of about 0.2 mg/mL;
- EDTA sodium in an amount of about 0.2 mg/mL;
- a sufficient amount of sterile water for injection;
- and
- a sufficient amount of a pH adjuster to obtain a pH of about 3.4.
6 more elements
A ready-to-use liquid formulation consisting of:
- lidocaine hydrochloride in an amount of about 10 mg/mL or about 20 mg/mL;
- epinephrine hydrochloride in an amount of about 10 mcg/mL, based on epinephrine free base;
- sodium chloride in an amount of about 7 mg/mL;
- sodium metabisulfite in an amount of about 5.2 mcg/mL;
- citric acid in an amount of about 0.2 mg/mL;
- EDTA sodium in an amount of about 0.2 mg/mL;
- a sufficient amount of sterile water for injection;
- and
- a sufficient amount of a pH adjuster to obtain a pH of about 3.4.
6 more elements
Dependencies are inferred from the claim text.